Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rmcr.2020.101176 http://scihub22266oqcxt.onion/10.1016/j.rmcr.2020.101176 32834986!7381914!32834986     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32834986&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Respir+Med+Case+Rep 2020 ; 31 (?): 101176 Nephropedia Template TP {{tp|p=32834986|t=2020. SARS-CoV2 induced pulmonary embolism and complications from anticoagulation |pdf=|usr=}}{{32834986}} gab.com Text SARS-CoV2 induced pulmonary embolism and complications from anticoagulation JO: Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32834986 #FOAvip Coronavirus disease (COVID-19) pandemic has rapidly spread around the world. As new complications associated with the virus become more apparent, concerns in the medical community continue to grow. One of the more commonly encountered and more troubling complications in critically ill patients has been hypercoagulable state and subsequent thrombotic events. Within the spectrum of observed thrombotic events, pulmonary embolism seems to prevail. These trends are concerning and reinforce current recommendations on anticoagulation in critically ill with the virus. To illustrate the variety of possible presentations of pulmonary emboli in COVID-19 population, two cases of patients in their sixties are described, one without any predisposing risk factors and one with history of asthma and obesity. These patients developed pulmonary emboli at different points during their hospital course, were treated differently, and had different outcomes. Important observations are made that may shed some light on possible etiology of pulmonary emboli. One of the patients presented still developed pulmonary embolism despite being on full dose anticoagulation. Literature review suggests that pulmonary clot burden in COVID-19 patients could be due to pulmonary thrombus rather than pulmonary embolism and is triggered by profuse vascular damage and severe inflammatory response. Literature review also proposes changes to the diagnostic work up in COVID-19 patients, such as earlier screening for pulmonary embolism in critically ill. In addition, rare and severe complications of current anticoagulation therapy is illustrated and discussed through one of the cases presented. Twit Text FOAVip SARS-CoV2 induced pulmonary embolism and complications from anticoagulation ????Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32834986 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32834986 #FOAvip English Wikipedia <ref>{{Cite pmid|32834986}}</ref> SARS-CoV2 induced pulmonary embolism and complications from anticoagulation #MMPMID32834986 Turshudzhyan A Respir Med Case Rep 2020[]; 31 (?): 101176 PMID32834986show ga Coronavirus disease (COVID-19) pandemic has rapidly spread around the world. As new complications associated with the virus become more apparent, concerns in the medical community continue to grow. One of the more commonly encountered and more troubling complications in critically ill patients has been hypercoagulable state and subsequent thrombotic events. Within the spectrum of observed thrombotic events, pulmonary embolism seems to prevail. These trends are concerning and reinforce current recommendations on anticoagulation in critically ill with the virus. To illustrate the variety of possible presentations of pulmonary emboli in COVID-19 population, two cases of patients in their sixties are described, one without any predisposing risk factors and one with history of asthma and obesity. These patients developed pulmonary emboli at different points during their hospital course, were treated differently, and had different outcomes. Important observations are made that may shed some light on possible etiology of pulmonary emboli. One of the patients presented still developed pulmonary embolism despite being on full dose anticoagulation. Literature review suggests that pulmonary clot burden in COVID-19 patients could be due to pulmonary thrombus rather than pulmonary embolism and is triggered by profuse vascular damage and severe inflammatory response. Literature review also proposes changes to the diagnostic work up in COVID-19 patients, such as earlier screening for pulmonary embolism in critically ill. In addition, rare and severe complications of current anticoagulation therapy is illustrated and discussed through one of the cases presented. ?SARS-CoV2 induced pulmonary embolism and complications from anticoagul(epmc).pdf DeepDyve Pubget Overpricing